TB 500 FDA Approval Status 2026: Thymosin Beta 4 Research & Regulation How to Get FDA Drug Approval Scilife FDA Peptide Reclassification 2026: What It Means for Providers The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is the FDA Poised to Reshape the Peptide Market